IDEAS home Printed from https://ideas.repec.org/e/pon103.html
   My authors  Follow this author

Phill Peter O'Neill

Personal Details

First Name:Phill
Middle Name:Peter
Last Name:O'Neill
Suffix:
RePEc Short-ID:pon103
http://ohe.org

Affiliation

Office of Health Economics

London, United Kingdom
http://www.ohe.org/

+44 (0) 20 7747 1440
+44 (0) 20 7691 7355
Southside, 7th Floor, 105 Victoria Street, London SW1E 6QT
RePEc:edi:ohecouk (more details at EDIRC)

Research output

as
Jump to: Working papers Articles Books

Working papers

  1. Cole, A. & Lundqvist, A. & Lorgelly, P. & Norrlid, H. & Karlsberg Schaffer, S. & Lewis, F. & Hernandez-Villafuerte, K. & Lindgren, P. & Garau, M. & Welin, K-O & Bianchi, S. & Althin, R. & O'Neill, P. , 2016. "Improving Efficiency and Resource Allocation in Future Cancer Care," Consulting Reports 001748, Office of Health Economics.
  2. O'Neill, P. & Sussex, J., 2015. "International Comparison of Medicines Usage: Quantitative Analysis from a Swedish Perspective," Consulting Reports 001611, Office of Health Economics.
  3. Lewis, F. & Karlsberg Schaffer, S. & Sussex, J. & O'Neill, P. & Cockcroft, L., 2014. "The Trajectory of Dementia in the UK - Making a Difference," Consulting Reports 000518, Office of Health Economics.
  4. O'Neill, P. & Mestre-Ferrandiz, J. & Puig-Peiro, R. & Sussex, J., 2014. "Projecting Expenditure on Medicines in the NHS: Second Edition," Research Papers 000070, Office of Health Economics.
  5. O'Neill, P. & Mestre-Ferrandiz, J. & Puig-Peiro, R. & Sussex, J., 2013. "Projecting Expenditure on Medicines in the NHS," Research Papers 000115, Office of Health Economics.
  6. Dakin, H. & Devlin, N. & Feng, Y. & Rice, N. & O'Neill, P. & Parkin, D., 2013. "The Influence of Cost-effectiveness and Other Factors on NICE Decisions," Research Papers 000107, Office of Health Economics.
  7. O'Neill, P. & Devlin, N. & Puig-Peiro, R., 2012. "Time Trends in NICE HTA Decisions," Consulting Reports 000169, Office of Health Economics.
  8. O'Neill, P. & Puig-Peiro, R. & Mestre-Ferrandiz, J. & Sussex, J., 2012. "International Comparisons of Medicines Prices: 2011 Indices," Consulting Reports 000144, Office of Health Economics.
  9. Baillie, L. & Hawe, E. & O'Neill, P. & Greville, R., 2011. "Health and the Use of Medicines in Primary Care in Wales," Consulting Reports 000001, Office of Health Economics.

Articles

  1. Helen Dakin & Nancy Devlin & Yan Feng & Nigel Rice & Phill O'Neill & David Parkin, 2015. "The Influence of Cost‐Effectiveness and Other Factors on Nice Decisions," Health Economics, John Wiley & Sons, Ltd., vol. 24(10), pages 1256-1271, October.

Books

  1. O'Neill, P., 2010. "Shedding the Pounds: Obesity Management, NICE Guidance and Bariatric Surgery in England," Monographs, Office of Health Economics, number 000204, January.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Lewis, F. & Karlsberg Schaffer, S. & Sussex, J. & O'Neill, P. & Cockcroft, L., 2014. "The Trajectory of Dementia in the UK - Making a Difference," Consulting Reports 000518, Office of Health Economics.

    Cited by:

    1. Panagiotis Kasteridis & Maria Goddard & Rowena Jacobs & Rita Santos & Anne Mason, 2015. "The impact of primary care quality on inpatient length of stay for people with dementia: an analysis by discharge destination," Working Papers 113cherp, Centre for Health Economics, University of York.
    2. Knapp, Martin & Comas-Herrera, Adelina & Wittenberg, Raphael & Hu, Bo & King, Derek & Rehill, Amritpal & Adelaja, Bayo, 2014. "Scenarios of dementia care: what are the impacts on cost and quality of life?," LSE Research Online Documents on Economics 57568, London School of Economics and Political Science, LSE Library.
    3. Lucy Webster & Derek Groskreutz & Anna Grinbergs-Saull & Rob Howard & John T O’Brien & Gail Mountain & Sube Banerjee & Bob Woods & Robert Perneczky & Louise Lafortune & Charlotte Roberts & Jenny McCle, 2017. "Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations," PLOS ONE, Public Library of Science, vol. 12(6), pages 1-22, June.

  2. O'Neill, P. & Mestre-Ferrandiz, J. & Puig-Peiro, R. & Sussex, J., 2014. "Projecting Expenditure on Medicines in the NHS: Second Edition," Research Papers 000070, Office of Health Economics.

    Cited by:

    1. Mestre-Ferrandiz, J. & Towse, A., 2014. "What is the Role of HTA for Biosimilars?," Briefings 000075, Office of Health Economics.

  3. O'Neill, P. & Mestre-Ferrandiz, J. & Puig-Peiro, R. & Sussex, J., 2013. "Projecting Expenditure on Medicines in the NHS," Research Papers 000115, Office of Health Economics.

    Cited by:

    1. O'Neill, P. & Mestre-Ferrandiz, J. & Puig-Peiro, R. & Sussex, J., 2014. "Projecting Expenditure on Medicines in the NHS: Second Edition," Research Papers 000070, Office of Health Economics.

  4. Dakin, H. & Devlin, N. & Feng, Y. & Rice, N. & O'Neill, P. & Parkin, D., 2013. "The Influence of Cost-effectiveness and Other Factors on NICE Decisions," Research Papers 000107, Office of Health Economics.

    Cited by:

    1. Mikael Svensson & Fredrik Nilsson & Karl Arnberg, 2015. "Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness," PharmacoEconomics, Springer, vol. 33(11), pages 1229-1236, November.
    2. Maynou, Laia & Cairns, John, 2018. "What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countries," LSE Research Online Documents on Economics 90877, London School of Economics and Political Science, LSE Library.
    3. Lisa Masucci & Jaclyn Beca & Mona Sabharwal & Jeffrey S. Hoch, 2017. "Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR)," PharmacoEconomics - Open, Springer, vol. 1(4), pages 255-263, December.
    4. Karlsberg Schaffer, S. & Sussex, J. & Hughes, D. & Devlin, N., 2014. "Opportunity Costs of Implementing NICE Decisions in NHS Wales," Research Papers 000517, Office of Health Economics.
    5. Peter Ghijben & Yuanyuan Gu & Emily Lancsar & Silva Zavarsek, 2018. "Revealed and Stated Preferences of Decision Makers for Priority Setting in Health Technology Assessment: A Systematic Review," PharmacoEconomics, Springer, vol. 36(3), pages 323-340, March.
    6. Maynou, Laia & Cairns, John, 2019. "What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countries," Health Policy, Elsevier, vol. 123(2), pages 130-139.
    7. Benedikt Schoser & Andreas Hahn & Emma James & Digant Gupta & Matthew Gitlin & Suyash Prasad, 2019. "A Systematic Review of the Health Economics of Pompe Disease," PharmacoEconomics - Open, Springer, vol. 3(4), pages 479-493, December.
    8. Jobjörnsson, Sebastian & Forster, Martin & Pertile, Paolo & Burman, Carl-Fredrik, 2016. "Late-stage pharmaceutical R&D and pricing policies under two-stage regulation," Journal of Health Economics, Elsevier, vol. 50(C), pages 298-311.
    9. J. Raftery, 2014. "NICE’s Cost-Effectiveness Range: Should it be Lowered?," PharmacoEconomics, Springer, vol. 32(7), pages 613-615, July.
    10. Rejon-Parrilla, J.C & Hernandez-Villafuerte, K. & Shah, K. & Mestre-Ferrandiz, J. & Garrison, L. & Towse, A., 2014. "The Expanding Value Footprint of Oncology Treatments," Consulting Reports 000050, Office of Health Economics.
    11. Shafrin, Jason & Skornicki, Michelle & Brauer, Michelle & Villeneuve, Julie & Lees, Michael & Hertel, Nadine & Penrod, John R. & Jansen, Jeroen, 2018. "An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?," Health Policy, Elsevier, vol. 122(6), pages 607-613.
    12. Pieter Baal & Alec Morton & David Meltzer & Werner Brouwer, 2019. "Future unrelated medical costs need to be considered in cost effectiveness analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(1), pages 1-5, February.
    13. Francesco Paolucci & Ken Redekop & Ayman Fouda & Gianluca Fiorentini, 2017. "Decision Making and Priority Setting: The Evolving Path Towards Universal Health Coverage," Applied Health Economics and Health Policy, Springer, vol. 15(6), pages 697-706, December.
    14. Shah, K. & Praet, C. & Devlin, N. & Sussex, J. & Appleby, J. & Parkin, D., 2011. "Is the Aim of the Health Care System to Maximise QALYs? An Investigation of," Research Papers 000180, Office of Health Economics.
    15. Anna Hobbins & Luke Barry & Dan Kelleher & Koonal Shah & Nancy Devlin & Juan Manuel Ramos Goni & Ciaran O’Neill, 2018. "Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L," PharmacoEconomics, Springer, vol. 36(11), pages 1345-1353, November.
    16. Fischer, Katharina Elisabeth & Heisser, Thomas & Stargardt, Tom, 2016. "Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia," Health Policy, Elsevier, vol. 120(10), pages 1115-1122.
    17. M. J. Walton & J. O’Connor & C. Carroll & L. Claxton & R. Hodgson, 2019. "A Review of Issues Affecting the Efficiency of Decision Making in the NICE Single Technology Appraisal Process," PharmacoEconomics - Open, Springer, vol. 3(3), pages 403-410, September.
    18. Carlos King Ho Wong & Olivia Wu & Bernard M. Y. Cheung, 2018. "Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions," Applied Health Economics and Health Policy, Springer, vol. 16(1), pages 5-14, February.
    19. Rejon-Parrilla, J.C & Garau, M. & Sussex, J., 2014. "Obstructive Sleep Apnoea: Health Economics Report," Consulting Reports 001504, Office of Health Economics.
    20. Cynthia P. Iglesias & Alexander Thompson & Wolf H. Rogowski & Katherine Payne, 2016. "Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations," PharmacoEconomics, Springer, vol. 34(11), pages 1161-1172, November.
    21. Shiroiwa, Takeru & Fukuda, Takashi & Ikeda, Shunya & Takura, Tomoyuki, 2017. "New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluations," Health Policy, Elsevier, vol. 121(8), pages 836-841.
    22. Angela Rocchi & Elizabeth Miller & Robert Hopkins & Ron Goeree, 2012. "Common Drug Review Recommendations," PharmacoEconomics, Springer, vol. 30(3), pages 229-246, March.

Articles

  1. Helen Dakin & Nancy Devlin & Yan Feng & Nigel Rice & Phill O'Neill & David Parkin, 2015. "The Influence of Cost‐Effectiveness and Other Factors on Nice Decisions," Health Economics, John Wiley & Sons, Ltd., vol. 24(10), pages 1256-1271, October.
    See citations under working paper version above.Sorry, no citations of articles recorded.

Books

    Sorry, no citations of books recorded.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Phill Peter O'Neill should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.